SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-000411
Filing Date
2022-01-06
Accepted
2022-01-06 09:34:34
Documents
1
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164147965932261.html 4  
1 FORM 4 wf-form4_164147965932261.xml 4 8907
  Complete submission text file 0001628280-22-000411.txt   10401
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Klimovsky Judith V (Reporting) CIK: 0001762247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 22513802